Navigation Links
Video: Provectus Pharmaceuticals Updates Shareholders On 2009 Year-To-Date Accomplishments
Date:8/11/2009

KNOXVILLE, Tenn., Aug. 11 /PRNewswire-FirstCall/ -- Provectus Pharmaceuticals, Inc. (OTC BB: PVCT) reports on its year-to-date clinical and corporate accomplishments in a letter to shareholders from Craig Dees, Ph.D., CEO of Provectus.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/pvct/39628/

Dear Shareholders:

I am pleased to report that 2009 has already been a year of continued progress and excitement for Provectus. Our clinical trials for both PV-10 and PH-10 have shown promising results. We have completed patient accrual in two of our ongoing Phase 2 trials -- PV-10 for metastatic melanoma and PH-10 for atopic dermatitis.

We believe the results show that PV-10 can be a viable treatment for metastatic melanoma, and we are focusing our efforts on completing the 80 patient study, while also making plans for our next steps in development. Those next steps include seeking licensure agreements and/or partnerships to proceed through final development, and ultimately, bringing the product to market. In addition, we intend to meet with the FDA to determine exactly what steps we need to take to obtain approval of PV-10 for metastatic melanoma.

Compelling data was presented at the American Society of Clinical Oncology (ASCO) meeting in May/June 2009. Interim data from the first 40 subjects in our Phase 2 clinical trial for the treatment of metastatic melanoma demonstrated an objective response (i.e. meaningful response) in 60% of subjects, with 75% of subjects achieving locoregional disease control of their treated lesions. Just over half (52%) of subjects had one or more evaluable untreated bystander lesions, and 48% of these subjects exhibited an objective response in those lesions. This bystander response was strongly correlated
'/>"/>

SOURCE Provectus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain
2. Video: American Dental Association Statement: Food and Drug Administration Action on Dental Amalgam
3. Video: Sodexo Takes on Childhood Obesity in School Cafeterias
4. Video: What Are Those Little Red Bumps?
5. Video: Perot Systems Unveils Series of Healthcare Video Case Studies
6. Video: FDA Approves Hologics Adiana(R) Permanent Contraception System
7. Video: New Online Film Introduces Longevinex Advantage(TM) -- The First Resveratrol-Based Dietary Supplement to Address Both Cellular and Connective Tissue Aging
8. Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment
9. Video: Gabrielle Reece Shows Natural is Beautiful in New PureVia(TM) Campaign
10. Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas
11. VIDEO: Cancer Treatment Centers of America Selects Site in GA for Proposed Hospital Serving Patients in Southeast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... military personnel who served in Iraq and Afghanistan ... injury (TBI) were compared to military personnel without ... Differences in measures of overall disability, cognitive function, ... are reported in an article in Journal ... Ann Liebert, Inc., publishers. The article is available ...
(Date:4/17/2014)... IL, April 17, 2014-- Colic affects about one in ... for numerous pediatric visits during the first several months ... colic symptoms was showing promise; however, the April 1, ... (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics and ... L reuteri for infant colic did ...
(Date:4/17/2014)... (SACRAMENTO, Calif.) An international team led by researchers ... protein complex, which plays a key role in cell ... process. This is the first time the complex has ... could make cyclin B1/Cdk1 an excellent target to control ... medicine. The research was published online today in the ...
(Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Unraveling the 'black ribbon' around lung cancer 2
... time you leave your home? You may not be ... University of British Columbia and Vancouver Coastal Health Research ... who, without apparent brain damage or cognitive impairment, is ... that there are many others in the general population ...
... provider of,business process outsourcing (BPO) solutions for health ... its board of directors. Pym was,singled out for ... companies on growth and strategic planning issues. Following ... Ehrmann LLP as,partner, Mr. Pym formed the Bruce ...
... the brink of phenomenal,growth, the administration of Physicians Health ... grow with it while it,created an overarching brand campaign ... that partnership with Blue Clover -- a versatile, fast,moving ... -- and named,it Agency of Record as of July ...
... discontinue several key anesthesia systems, DRE Medical Equipment is ... ... Louisville, KY (Vocus) ... http://www.dremed.com [surgical and medical equipment supplier], recently ...
... Ever "Pulse of the Industry Report" at,Conference, ... kicks off with the release of the first ... Medical Technology" report, nearly 20 next,generation company presentations, ... of the world,s most advanced medical technology, surgical ...
... our healing? Since 2005 DreamHealer has collected data on ... and visualizations. The results were analyzed (by Statistics Made ... testing. With a sample base of over 2500 participants ... do healing visualizations showed improvement in their health. 30% ...
Cached Medicine News:Health News:Getting lost -- a newly discovered developmental brain disorder 2Health News:Adaptis Names Bruce Pym to the Board Of Directors 2Health News:Physicians Health Choice Hires Blue Clover as Agency of Record 2Health News:DRE Medical Equipment Offers Valuable Discounts to GE Healthcare Customers 2Health News:AdvaMed 2008 Opens Showcasing Latest Medical Technologies with Innovation Alley Exhibit and Next Generation Company Presentations 2Health News:Dreamhealer Encourages Global Healing of Those Affected by Disasters or Illness 2
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... GARDENS, Fla. , Jan. 15, 2014  In an unprecedented effort ... and TB in ambulances and other transport vehicles, an advanced and ... by rescue personnel for the first time. In ... contact with these deadly pathogens, West Palm Beach ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... The Soft Boston Scoliosis Brace™ ... support is a lightweight, soft, ... designed for maximum comfort. ... is constructed of non-cracking orthopedic ...
An indirect immunofluorescence antibody test for the qualitative and semi-quantitative detection of endomysial antibodies (EMA) in human serum as an aid in the diagnosis of celiac disease and dermati...
Urethrotome - non-optical...
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
Medicine Products: